V

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Associate Director - Quality Control

Regulatory & Quality (Life Sciences)Updated on Nov 11
Full-timeWaltham, MA, USA

About the Job

Requirements

  • A Master's degree with at least 8 years of relevant experience, or a Bachelor's degree with at least 10 years of experience in biopharmaceutical quality control or analytical development.
  • Demonstrated experience with QC analytical method lifecycle activities for biologics, including method transfer, validation, performance monitoring, improvement, and expansion to support EU regulatory and market requirements.
  • Experience working with contract laboratories and external manufacturing partners, including data review, technical issue resolution, and partner oversight.
  • Experience supporting regulatory inspections and health authority interactions.
  • Strong technical knowledge of analytical, bioanalytical, and device test methods used for biopharmaceutical and combination products, including ELISA, chromatography (HPLC/UPLC), electrophoresis, spectroscopy, compendial methods, and device functional performance testing.
  • Experience leading investigations and quality system processes, including deviations, out-of-specification and out-of-trend investigations, corrective and preventive actions, and change control.
  • Proficiency with data analysis tools and statistical methods, such as JMP, supporting specification setting and method performance trending, and knowledge of data integrity expectations in regulated environments.
  • Strong written and verbal communication skills and experience preparing technical and regulatory documentation.
  • Proficiency with Microsoft Office Suite, including Word, PowerPoint, Excel, Outlook, and SharePoint.
  • Ability to travel up to 10%.

Responsibilities

  • Manage Viridian’s stability program performed by outside testing laboratories, including managing contract manufacturing organizations and contract testing laboratories, reviewing data, and preparing certificates of analysis.
  • Provide strategic leadership to the QC Analytical team, including oversight of external partners to support all stages of program development.
  • Develop and evolve phase-appropriate specifications, reference standards, and critical reagents in accordance with global regulatory requirements.
  • Analyze and communicate complex analytical data to internal stakeholders, senior leadership, and external partners.
  • Establish priorities, lead cross-functional activities, and ensure timely delivery of QC commitments through effective influence and collaboration.
  • Lead method lifecycle management for QC-owned methods, including transfers, validations, performance monitoring, improvements, and change impact assessments.
  • Provide strategic and operational leadership for external contract manufacturing organizations and contract testing laboratories supporting analytical testing, stability, and product release activities for clinical-stage biopharmaceutical and combination products; ensure accountability for performance, quality, timelines, issue resolution, and escalation.
  • Align technical expectations across internal teams and external partners, review data and deliverables, resolve issues, and drive partner accountability.
  • Identify and escalate analytical, compliance, or execution risks early, with a recommended path forward.
  • Lead or support deviation and out-of-specification/out-of-trend investigations, and implement robust root cause analysis and corrective actions.
  • Contribute to chemistry, manufacturing, and controls regulatory submissions, including investigational new drug applications, biologics license applications, and global filings and regulatory inquiries; support inspection readiness activities and vendor audits.
  • Serve as the QC subject matter expert during inspections and regulatory inquiries.
  • Partner with Quality Assurance, Regulatory Affairs, Manufacturing, and Technical Development to ensure alignment across the product lifecycle.

About the Company

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Viridian Therapeutics

See more jobs